News and blog posts

24

Mar 2023

On March 2, 2023, the decision of the National Union of Health Insurance Funds relating to the update of the CCAM Nomenclature of procedure codes was published in the Official Journal of the French Republic. Changes include registration of new procedure codes, modification and removal of some existing codes. Newly introduced codes concern cardiovascular procedures, interventional radiology, orthopedics, peripheral vascular procedures, and others. Read more

23

Mar 2023

In February 2023, the Scottish Health Technology Group, SHTG, released three MedTech-related assessments: selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma, Feeling Good app, store-and-forward teledermatology for triage of primary care referrals. Read more

22

Mar 2023

A new preeclampsia screening algorithm has been evaluated within the "New Method" framework since 2021. The algorithm helps to predict the risk of preeclampsia in the first trimester based on several parameters, including ultrasound examination and measurement of the Placenta Growth Factor (PIGF). In March 2023, the Decision Forum for "New Method" was held and commissioned to perform the implementation study of a new screening algorithm at St. Olav's Hospital. Read more

21

Mar 2023

On March 8, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the coverage of the INTERVAPOR system for lung volume reduction under Forfait innovation program. Read more

20

Mar 2023

On March 1, 2023, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) updated three Articles of the Nomenclature related to in-vitro diagnostics. Twelve new codes concerning clinical biology, molecular biology for infections, and genetics were implemented. Read more

20

Mar 2023

Since 2017 MTRC has provided reimbursement and HEOR services for the medical device and IVD industry in Europe. We specialize in Pan-European projects and worked in 34 countries in Europe. In this post, we summarized statistics about our experience with reimbursement projects in different EU countries. Three leading countries are England (273 projects), Germany (247 projects), and France (203 projects). Read more

20

Mar 2023

MTRC is the leading provider of market access services in Europe. Since 2017 we have accomplished 700+ projects in Europe. We provide regular consulting services to 56% of top 30 med tech companies and multiple SMEs. The typical scope of model adaptation includes adjustment of epidemiological data, validation of comparator, an adaptation of resource use and cost data, and search for local utility data. MTRC has a unique ability to work on model adaptations due to its unparalleled knowledge of payment systems in 34 European countries. We worked on model adaptations in Belgium, Denmark, Finland, France, Germany, Italy, Norway, the Netherlands, Poland, Russia, Spain, Sweden, and the UK. Read more

20

Mar 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Conrads-Frank et al. performed a critical review of decision-analytic modeling studies to inform early HTA for high-risk medical devices. The study presented a summary of methodological approaches, and made a number of recommendations about technical aspects of health economic analysis for medical devices. Read more

17

Mar 2023

On March 2, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of six prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 16, 2023. Read more

16

Mar 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Horgan et al. completed a survey of the status of Next-Generation Sequencing (NGS) in Europe and globally. Based on the feedback from 62 experts, a framework for implementation of the NGS is proposed along with in-depth discussion about current aspects of demand-and supply-side issues, governance and strategy, clinical standardization, awareness and education, equipment used, reimbursement and funding. Read more

16

Mar 2023

In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023. Read more

15

Mar 2023

In March 2023, a new ‘AI and Digital Regulations Service’ for developers and adopters of artificial intelligence (AI) and digital technologies was launched in England. Four organizations provide this multi-agency advisory service: NICE, Care Quality Commission, Medicines and Healthcare products Regulatory Agency, and Health Research Authority. The website is currently in public beta and focused on information for developers. Read more